Companies similar to ABREGEN
Sign up to Download

31-60 of 5,637,126 results

  • vivacellspain.com
  • 2
  • 1
  • 14
Vivacell Biotechnology España SLU, a wholly owned subsidiary of Emerald Health Research (Canada), is a preclinical-stage pharmaceutical company based in Córdoba, Spain. Vivacell is a worldwide pioneer company in the discovery and development of novel..
Relevance: 30.453451
  • alligatorbioscience.se
  • 4
  • 2
  • 18
Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies...
Relevance: 30.227179
  • cantargia.com
  • 3
  • 2
  • 13
Cantargia is a Swedish biotechnology company that specializes in the development of pharmaceuticals for various types of cancer and inflammatory/autoimmune diseases. Our development programme includes the candidate drugs nadunolimab (CAN04) and..
Relevance: 29.965776
  • interiusbio.com
  • 1
  • 1
  • 15
Interius BioTherapeutics is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of..
Relevance: 29.940586
  • www.mediapharma.it
  • 3
  • 1
  • 3
MediaPharma Srl is a preclinical stage biotech company focusing on research and development of monoclonal antibodies, Antibody-Drug Conjugates (ADCs) and other products for the treatment of cancer and other severe diseases with high unmet medical..
Relevance: 29.812002
  • www.ictbio.com
  • 1
  • 2
  • 5
Innovative Cellular Therapeutics (ICT) is a private clinical stage biotechnology company headquartered in Rockville, MD. ICT is focused on the development of cellular immunotherapies for the treatment of solid tumors. ICT's unique CoupledCAR®..
Relevance: 29.630468
  • abnexllc.com
  • 1
Abnex is a privately owned Biotechnology R&D company. We are dedicated to the discovery and development of antibody-based next-generation therapy for human grievous diseases, including cancers, infectious & inflammatory diseases, and..
Relevance: 29.58688
  • www.amyltx.com
  • 6
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treat rare and severe peripheral protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we..
Relevance: 29.445889
  • pyramidbio.com
  • 1
  • 18
Pyramid Biosciences Expands Oncology Pipeline with In-Licensing of GQ1010, a Potentially Best-in-Class TROP2 Targeted Antibody Drug Conjugate (ADC) from GeneQuantum Healthcare... We are a clinical-stage, oncology focused biotechnology company..
Relevance: 29.39721
  • epsilogen.com
  • 1
  • 1
  • 13
Epsilogen is also developing IgEG™ platform technology based on combining the power of IgE and IgG antibody molecules. Preclinical Proof of Concept has been established for this novel antibody class... Epsilogen a leading innovator in industrial..
Relevance: 29.375822
  • www.sutrobio.com
  • 6
  • 3
  • 28
Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients... Sutro Biopharma, Inc. is a public biotechnology..
Relevance: 29.299011
  • www.repairbiotechnologies.com
  • 1
  • 1
  • 5
Repair Biotechnologies is a late preclinical-stage biotech company developing several first-in-class therapies based on the Cholesterol Degrading Platform (CDP)... We are Repair Biotechnologies, a late-stage preclinical-stage biotech company..
Relevance: 29.274643
  • www.saillanttherapeutics.nl
  • 1
  • 1
After preclinical development of new drug candidates, Saillant Therapeutics is interested in pursuing licensing agreements with established pharmaceutical and biotech companies to enable further clinical development, registration and..
Relevance: 29.096312
  • adalta.com.au
  • 1
  • 1
  • 12
AdAlta Limited (ASX:1AD) is a clinical stage biotechnology company using its i-body platform to discover and develop next generation protein therapeutics addressing drug targets that are challenging for other technologies... AdAlta Limited was..
Relevance: 28.910208
  • biologyservices.com
Welcome to Biology CRO informational resource for life science and pharmaceutical researchers. This website provides a list of contract research organizations (CRO) that offer various pharmacology and biotechnology laboratory services to..
Relevance: 28.896822
  • www.toreatechnologies.net
  • 2
TOREA TECHNOLOGIES IS ENGAGED IN RESEARCH, DESIGN AND DEVELOPMENT OF BIOTECHNOLOGY DERIVED ANTIBODY PHARMACEUTICALS..
Relevance: 28.885538
  • www.planetbiotechnology.com
  • 1
  • 1
  • 4
Planet Biotechnology produced the first plant-made antibody, or "plantibody", ever tested in a clinical trial. We are focused on discovering, developing and commercializing new antibody-based therapeutic and preventative products through cultivation..
Relevance: 28.846039
  • asyliatx.com
  • 1
  • 3
Asylia Therapeutics is a private development stage biotechnology company committed to transforming scientific advances into safe and effective medicines for cancer and auto-immune diseases. Founded in 2019 and based in Houston, Texas, the company is..
Relevance: 28.75831
  • traconpharma.com
  • 3
  • 2
  • 13
is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, Our lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of..
Relevance: 28.53055
  • www.glycotope.com
  • 2
  • 3
  • 13
Glycotope is a biotechnology company utilizing a proprietary technology platform to develop uniquely tumor-specific monoclonal antibodies. We combine expertise in glycobiology and know-how in antibody development to advance first-in-class antibody-..
Relevance: 28.482347
  • www.cytodyn.com
  • 2
  • 2
  • 20
CytoDyn is a publicly traded late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on Leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 appears to play a key..
Relevance: 28.444504
  • www.adagene.com
  • 5
  • 2
  • 22
Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer... Adagene (NASDAQ: ADAG) is a publicly traded, global, clinical-stage..
Relevance: 28.426971
  • www.bionecure.com
  • 1
BiOneCure Therapeutics Inc. is a biotechnology company committed to the discovery and development of innovative medicines for the treatment of cancer and enhancing cancer patients' lives... We are a start-up company dedicated to developing antibody-..
Relevance: 28.420818
  • www.lindanbiotech.com
  • 1
Lindan Biotech is a Canadian based contract research organization (CRO) company and our mission is to provide the highest-quality preclinical efficacy contract services for cancer animal model to our Clients, who include biotech and pharmaceutical..
Relevance: 28.30024
  • www.hylascobio.in
  • 1
  • 1
Hylasco Biotechnology India Private Limited provides essential products and services to help pharmaceutical and biotechnology companies, government research agencies and leading Public and Private academic institutions in India accelerate their..
Relevance: 28.274004
  • abzymetx.com
  • 1
  • 1
  • 3
Abzyme Therapeutics is a biopharmaceutical discovery and service company with expertise in modular antibody discovery and conditionally-active antibody engineering for immunotherapy using proprietary antibody generation and optimization platforms...
Relevance: 28.260551
  • sporosbioventures.com
  • 9
Sporos has an internal drug discovery platform and pipeline of wholly-owned preclinical assets. In addition, Sporos has established multiple asset team units, or portfolio companies, which intently focus on R&D and draw from Sporos' central..
Relevance: 28.188173
  • www.g2therapies.com
  • 1
  • 1
  • 4
G2 is a privately funded biotechnology company esablished in 2002 to develop and commercialise novel antibody based therapies in inflammation and cancer. The company is based at the Garvan Institute of Medical Research, one of the largest medical..
Relevance: 28.14126
  • kintsugitx.com
  • 1
Kintsugi Therapeutics is a preclinical-stage biopharmaceutical Barcelona based company focused on the development of innovative therapies targeting the regulation of endoplasmic reticulum stress for the treatment of liver conditions and other..
Relevance: 28.105892
  • www.monopartx.com
  • 1
  • 1
  • 8
Monopar Therapeutics is a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, including Phase 1-stage MNPR-101-Zr for imaging advanced cancers and late preclinical-stage MNPR-101 radio-immuno-..
Relevance: 28.072731